---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-048815"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:42:02.117790+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# agilon health Q3 net loss $110M; re-establishes FY2025 guidance with negative EBITDA outlook

## Summary
- Q3 2025 revenue $1.44B, down 1% YoY; net loss $110M vs $118M loss in Q3 2024.
- Adjusted EBITDA loss $91M; medical margin negative $57M; gross profit negative $68M.
- Total members 618,000 (503k MA, 115k ACO), down 6% YoY due to market exits.
- Full-year 2025 guidance: revenue $5.81B-$5.83B; adjusted EBITDA loss ($270M)-($245M).
- Expects $30M operating cost reductions in 2026; risk adjustment revenue shortfall of $73M in Q3.

## SEC filing metadata
- accession: 0001628280-25-048815
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828025048815/0001628280-25-048815-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828025048815/agl-20251104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-048815
- JSON: https://secwatch.observer/filing/0001628280-25-048815.json
- Plain text: https://secwatch.observer/filing/0001628280-25-048815.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.